¡°Slightly technical, eminently readable, consistently shocking, occasionally hectoring and unapologetically polemical . . . This is a book that deserves to be widely read, because anyone who does read it cannot help feeling both uncomfortable and angry.¡± ¡ªThe Economist
¡°Ben Goldacre has done it again . . . This is a morbidly fascinating and dispiriting account, yet one which deserves (and needs) to be read and acted upon without delay.¡± ¡ªDennis Rosen, Dennis Rosen, The Boston Globe
¡°Read this book. It will make you mad, it will make you scared. And, hopefully, it will bring about some change. ¡± ¡ªChris Lee, Ars Technica
¡°A thorough piece of investigative medical journalism. What keeps you turning its pages is the accessibility of Goldacre's writing, . . . his genuine, indignant passion, his careful gathering of evidence and his use of stories, some of them personal, which bring the book to life.¡± ¡ªLuisa Dillner, The Guardian
¡°Goldacre's research is scrupulous, and lay readers may find themselves converted by his geeky ardor. ¡± ¡ªThe New Yorker
¡°[A]n eye-opening glance into a world of experts who have failed us.¡± ¡ªThe New York Times Book Review
¡°In this searing expos? of the pharmaceutical industry, physician and journalist Goldacre uncovers a cesspool of corrupt practices designed to sell useless or dangerous drugs to an unsuspecting public . . . Goldacre conveys complicated scientific, medical, and ethical issues in simple, clear, plainspoken language that pulls no punches. The result is a smart, infuriating diagnosis of the rotten heart of the medical-industrial complex.¡± ¡ªPublishers Weekly
¡°A useful guide for policymakers, doctors and the patients who need protection against deliberate disinformation.¡± ¡ªKirkus Reviews
¡°Goldacre's essential expos? will prompt readers to ask more questions before automatically popping a doctor-prescribed pill.¡± ¡ªKaren Springen, Booklist
¡°Smart, funny, clear, unflinching: Ben Goldacre is my hero.¡± ¡ªMary Roach, author of Stiff, Spook, and Bonk, on Bad Science
Contents
1 Missing Data
2 Where Do New Drugs Come From?
3 Bad Regulators
4 Bad Trials
5 Bigger, Simpler Trials
6 Marketing
Afterword: Better Data
Glossary
Acknowledgements, Further Reading, and a Note on Errors
Notes
Index